The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of conversion surgery after apatinib in combination with S-1/oxaliplatin (SOX) for patients with unresectable gastric cancer (Ahead-BG301 trial).
 
Lin Chen
No Relationships to Disclose
 
Kecheng Zhang
No Relationships to Disclose
 
Bo Wei
No Relationships to Disclose
 
Xin Guo
No Relationships to Disclose
 
Hongqing Xi
No Relationships to Disclose
 
Jiyang Li
No Relationships to Disclose
 
Jianxin Cui
No Relationships to Disclose
 
Yunhe Gao
No Relationships to Disclose
 
Wenquan Liang
No Relationships to Disclose
 
Yixun Lu
No Relationships to Disclose